Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Khiron Life Sciences Corp.
  6. News
  7. Summary
    KHRN   CA49374L3065

KHIRON LIFE SCIENCES CORP.

(KHRN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Khiron Life Sciences Corp.: Invitation to the Q3 Virtual Investor Summit

08/11/2021 | 07:05am EDT

Toronto, Ontario--(Newsfile Corp. - August 11, 2021) - Khiron Life Sciences Corp. (TSXV: KHRN) today announced that Alvaro Torres will be attending the Q3 Virtual Investor Summit.

 Event Q3 Investor Summit
 Date August 17-18th, 2021
 Presentation August 17th at 10:15 ET
 Location https://zoom.us/webinar/register/WN_B3t_FX5BTbSU28vXaAEXHg

 

About Khiron Life Sciences Corp.

Khiron is a leading vertically integrated medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health centres and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico in 2021. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.

For further information:

Khiron Life Sciences Corp.
Paola Ricardo
+1 (647) 556-5750
investors@khiron.ca

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.

To request complimentary investor registration, please click here: Complimentary Investor Registration

Contact:

Sasha Murray at sasha@investorsummitgroup.com


ę Newsfilecorp 2021
All news about KHIRON LIFE SCIENCES CORP.
10/07KHIRON LIFE SCIENCES : Medical Cannabis Company Khiron Life Sciences Outlines Results of F..
MT
10/07KHIRON LIFE SCIENCES CORP. : Invitation to the Benzinga Cannabis Capital Conference
NE
10/07Khiron Life Sciences Corp. Presents Its First Research Study with 1,400 Patients
CI
10/04KHIRON LIFE SCIENCES : to Present at Upcoming October Investor Conferences
AQ
10/04KHIRON LIFE SCIENCES : Details Operations Update as CFO Resigns
MT
10/01Khiron Life Sciences Corp. Announces Management Changes
CI
09/13KHIRON LIFE SCIENCES : Renews Normal Course Issuer Bid
MT
09/09KHIRON LIFE SCIENCES : Announces Intention to Renew Normal Course Issuer Bid
MT
09/09Khiron Life Sciences Corp. announces an Equity Buyback for 8,955,893 shares, representi..
CI
09/09Khiron Life Sciences Corp. authorizes a Buyback Plan.
CI
More news
Financials
Sales 2021 13,0 M 10,5 M 10,5 M
Net income 2021 -22,2 M -18,0 M -18,0 M
Net Debt 2021 15,0 M 12,1 M 12,1 M
P/E ratio 2021 -1,33x
Yield 2021 -
Capitalization 47,5 M 38,5 M 38,4 M
EV / Sales 2021 4,81x
EV / Sales 2022 2,13x
Nbr of Employees -
Free-Float 94,7%
Chart KHIRON LIFE SCIENCES CORP.
Duration : Period :
Khiron Life Sciences Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KHIRON LIFE SCIENCES CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,27 CAD
Average target price 0,85 CAD
Spread / Average Target 221%
EPS Revisions
Managers and Directors
┴lvaro F. Torres Chief Executive Officer & Director
Swapan Kakumanu Chief Financial Officer
Chris Naprawa Chairman
Jairo Espinoza Vice President-Medical Affairs
Manuel Buendia Vice President-Operations
Sector and Competitors